News About: Pharm. Industry
Listed pharmas taking 101 days to turn over receivables after selling medicines
Listed pharmaceutical companies reportedly took about 101 days on average to return money they spent from selling medicinal drugs.
Yakup Shinmoon(www.yakup.com) analyzed the KOSPI and KOSDAQ listed pharmaceutical com...
How long KPBMA will leave Chairman position empty?
The Chairman position of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association is expected to continue absence by the 2nd quarter of the year.
The Korea Pharmaceutical and Bio-Pharma Manufacturers Associa...
Ilyang Pharm begins to export new drug ‘Noltec’ to Mexico
Ilyang Pharm(CEO Dong-Yeon Kim) announced the company has started to export ‘Noltec(generic name: ilaprazole),’ a new acid reflux treatment, to the Latin America under an agreement with the Mexican pharmaceutical comp...
When KPBMA will start to handle affairs of the association?
Established at the general meeting on 22 February, the ‘Chair Jung-Hee Lee & Vice Chairman Won-Il Gal’ administration will start to handle affairs of the association this April.
According to the pharmaceutical indust...
Listed pharmas owning KRW 1.9 trillion cashable assets
Cashable assets owned by listed pharmaceutical companies were reported decreased to approximately KRW 1.9 trillion compared to the year of 2016.
Yakup Shinmoon(www.yakup.com) analyzed 2017 audit reports that 64 KOSPI...
LG Chem acquires approval of the first antibody biosimilar ‘Eucept’
LG Chem will aim for the Korean antibody biosimilar market.
LG Chem announced on the 16th that the company acquired approval of ‘Eucept,’ a biosimilar product referencing ‘etanercept,’ an autoimmune disease treatment...
Most listed pharmas re-appoint their CEO at the general meeting day
In the Stockholders’ Super General Meeting Day on March 16th, most CEOs with expired contract were reappointed.
Only did 2 companies – Chong Kun Dang Holdings and Sam Chun Damg Pharm – appoint a new CEO, but 10 pharm...
Samsung Biologics with KRW 464.6 billion sales
Samsung Biologics achieved KRW 464.6 billion sales last year based on the March audit report, growing 57.7% up compared to the same period of time year before.
They turned operating profits from deficits to KRW 60 bi...
Listed pharmas to take 67 days to turnover all the manufactured products on average
It reportedly takes 67 days on average to exhaust all the items in their storage and the number of days was increased by 2 days compared to 2016.
Yakup Shinmoon(www.yakup.com) analyzed the 2017 audit report that list...
Medical representatives & distributors having difficulties due to fierce competition among CSOs
Dishonored as ‘front desk for illegal rebates,’ CSOs(contract sales organizations) paying a role as illegal rebate deliverers have created difficulties on distributors as keeping doing what they used to.
Distributors...
